Satellos Bioscience Inc. is a Canadian biotechnology company dedicated to developing novel therapeutics for muscle regeneration. The company's research is centered on understanding and modulating the polarity of muscle stem cells to enhance their regenerative capacity. Satellos aims to address unmet medical needs in conditions characterized by muscle degeneration, such as Duchenne muscular dystrophy (DMD) and other muscular dystrophies. Through its proprietary technology platform, Satellos is working to bring innovative treatments to patients suffering from debilitating muscle disorders.